Dräger’s Drug Testing Devices Earn Top Performance Ratings by the U.S. National Highway Traffic Safety Administration (NHTSA)

Dräger DrugTest 5000 (DDT5000) and Dräger DrugCheck 3000 (DDC3000) received best overall performance ratings in an evaluation report by the National Highway Traffic Safety Administration (NHTSA) and the Governors Highway Safety Association (GHSA).

The purpose of the report, “Evaluation of On-Site Oral Fluid Drug Screening Technology,” was to evaluate field oral fluid drug testing devices to assess their accuracy, reliability, performance to manufacturer specification, susceptibility to interference and resistance of the consumables to extremes of temperature and humidity.

Two previous studies that tested oral fluid testing devices were used to determine the scope of testing and cutoff concentrations for NHTSA’s evaluation. “The Roadside Testing Assessment” (ROSITA), that recommends greater than 90 percent sensitivity and specificity, and greater than 95 percent accuracy, and the “Driving Under the Influence of Drugs, Alcohol and Medicines” (DRUID) project, that recommends greater than 80 percent sensitivity, specificity and accuracy. Dräger’s DDT5000 and the DDC3000 were the only devices that met the performance requirements of both ROSITA and DRUID.

The Dräger DrugTest® 5000 and Dräger DrugCheck® 3000 can detect the presence of THC, cocaine, amphetamines, methamphetamines, opioids, Benzodiazepines and ketamine.

Oral fluid testing is none invasive, accurate, and works well for detection of recent usage.  The Dräger DrugTest systems can be used to find out within minutes if a person has recently consumed up to eight classes of drugs, and yields reliable results hygienically, quickly and reliably. Contact one of our safety experts today to find out more.